Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix Immunogenicity and Safety in Healthy Adults
NCT00100399Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2004
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Fluarix in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2004; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00100399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100399.